- Home
- SXTC vs JYNT Comparison
SXTC vs JYNT Comparison
Compare SXTC & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- JYNT
- Stock Information
- Founded
- SXTC 2005
- JYNT 2010
- Country
- SXTC China
- JYNT United States
- Employees
- SXTC N/A
- JYNT N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- JYNT Multi-Sector Companies
- Sector
- SXTC Health Care
- JYNT Miscellaneous
- Exchange
- SXTC Nasdaq
- JYNT Nasdaq
- Market Cap
- SXTC 164.8M
- JYNT 170.3M
- IPO Year
- SXTC 2019
- JYNT 2014
- Fundamental
- Price
- SXTC $1.90
- JYNT $10.26
- Analyst Decision
- SXTC
- JYNT Strong Buy
- Analyst Count
- SXTC 0
- JYNT 3
- Target Price
- SXTC N/A
- JYNT $16.33
- AVG Volume (30 Days)
- SXTC 860.1K
- JYNT 81.4K
- Earning Date
- SXTC 01-01-0001
- JYNT 11-06-2025
- Dividend Yield
- SXTC N/A
- JYNT N/A
- EPS Growth
- SXTC N/A
- JYNT N/A
- EPS
- SXTC N/A
- JYNT N/A
- Revenue
- SXTC $1,740,907.00
- JYNT $53,449,713.00
- Revenue This Year
- SXTC N/A
- JYNT $8.06
- Revenue Next Year
- SXTC N/A
- JYNT $11.18
- P/E Ratio
- SXTC N/A
- JYNT N/A
- Revenue Growth
- SXTC N/A
- JYNT 277.36
- 52 Week Low
- SXTC $0.95
- JYNT $9.58
- 52 Week High
- SXTC $7.84
- JYNT $13.47
- Technical
- Relative Strength Index (RSI)
- SXTC 60.38
- JYNT 41.89
- Support Level
- SXTC $1.33
- JYNT $9.85
- Resistance Level
- SXTC $1.97
- JYNT $10.74
- Average True Range (ATR)
- SXTC 0.21
- JYNT 0.22
- MACD
- SXTC 0.05
- JYNT -0.03
- Stochastic Oscillator
- SXTC 81.91
- JYNT 45.05
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.